Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

InSite Vision signs agreement with U. of California for glaucoma gene rights

May 4, 1999

Allergen patents new thromboxane receptor ligands with particular utility in ocular hypertension

May 3, 1999

Alcon to continue Lu-Tex development

April 27, 1999

Steroidogenesis inhibitor tested in mouse model of hereditary blindness

April 15, 1999

Eye implant receives FDA approval for correcting mild myopia

April 13, 1999

PhotoVision in-licenses novel technology for development of AMD treatment

April 7, 1999

Xalatan approved in Japan for glaucoma and ocular hypertension

March 16, 1999

Licensing opportunity from the NIH: antiinflammatory cytokine

March 4, 1999

Placebo-controlled study supports the efficacy of Alrex in seasonal allergic conjunctivitis

March 1, 1999

Worldwide strategic alliance established by Agennix and Santen for lactoferrin

Feb. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...